Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Montserrat Politics Today.
Press releases published on June 26, 2025
RECKITT BENCKISER SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Reckitt Benckiser Group PLC - RBGLY
GlobeNewswire
·
June 26, 2025
NEW ORLEANS, La., June 25, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until August 4, 2025 to file lead plaintiff applications in a securities class action lawsuit against Reckitt …
TEMPUS AI SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Tempus AI, Inc. - TEM
GlobeNewswire
·
June 26, 2025
NEW ORLEANS, June 25, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until August 12, 2025 to file lead plaintiff applications in a securities class action lawsuit against Tempus AI, Inc. ( …
RED CAT SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Red Cat Holdings, Inc. - RCAT
GlobeNewswire
·
June 26, 2025
NEW ORLEANS, June 25, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until July 22, 2025 to file lead plaintiff applications in a securities class action lawsuit against Red Cat Holdings, Inc. …
ORGANON SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Organon & Co. - OGN
GlobeNewswire
·
June 26, 2025
NEW ORLEANS, June 25, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until July 22, 2025 to file lead plaintiff applications in a securities class action lawsuit against Organon …
COMPASS DIVERSIFIED SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Compass Diversified Holdings - CODI
GlobeNewswire
·
June 26, 2025
NEW ORLEANS, June 25, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until July 8, 2025 to file lead plaintiff applications in a securities class action lawsuit against Compass Diversified …
מועד אחרון לתביעה נגד CODI: רוזן, יועץ למשקיעים גלובלי, מעודד את המשקיעים ב- Compass Diversified Holdings להשיג ייעוץ לפני המועד האחרון החשוב של 8 ביולי בתביעה ייצוגית בניירות ערך שהוגשה לראשונה על ידי המשרד - COD…
GlobeNewswire
·
June 26, 2025
ניו יורק, June 26, 2025 (GLOBE NEWSWIRE) -- מדוע: משרד רוזן עורכי דין (Rosen Law Firm), משרד עורכי דין בינלאומי העוסק בזכויות משקיעים, מזכיר לרוכשים את ניירות הערך של Compass Diversified Holdings (NYSE: CODI) בין התאריכים 1 במאי 2024 עד 7 במאי 2025, שני …
מועד אחרון לתביעה נגד LPRO: רוזן, יועץ למשקיעים מוביל, מעודד משקיעים ב- Open Lending Corporation להשיג ייעוץ לפני המועד האחרון החשוב של 30 ביוני בתביעה ייצוגית בניירות ערך - LPR…
GlobeNewswire
·
June 26, 2025
ניו יורק, June 26, 2025 (GLOBE NEWSWIRE) -- מדוע: משרד רוזן עורכי דין (Rosen Law Firm), משרד עורכי דין בינלאומי העוסק בזכויות משקיעים, מזכיר לרוכשים את ניירות הערך של Open Lending Corporation (נאסד"ק: LPRO) בין התאריכים 24 בפברואר 2022 עד 31 במרץ 2025, שני …
HIMS INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead the Hims & Hers Class Action Lawsuit
GlobeNewswire
·
June 26, 2025
SAN DIEGO, June 25, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman …
Hummingbird Bioscience Licenses HMBD-002, Phase II-Ready Anti-VISTA Monoclonal Antibody to Percheron Therapeutics
GlobeNewswire
·
June 26, 2025
Percheron Therapeutics obtains exclusive worldwide rights to Hummingbird Bioscience’s anti-VISTA mAb for further clinical development Hummingbird Bioscience stands to receive up to USD 290 million in upfront and milestone payments, plus royalties, from …
Iovance’s (IOVA) CFO Resigns Amid Launch Setbacks and Legal Pressure– Hagens Berman
GlobeNewswire
·
June 26, 2025
SAN FRANCISCO, June 25, 2025 (GLOBE NEWSWIRE) -- Biotechnology firm Iovance Biotherapeutics Inc. (NASDAQ: IOVA) announced a significant leadership transition, confirming the resignation of Chief Financial Officer Jean-Marc Bellemin, effective July 10, 2025 …
Rocket Pharmaceuticals, Inc. (RCKT) Faces Securities Class Action Amid Protocol Change and FDA’s Clinical Hold on Gene Therapy Trial – Hagens Berman
GlobeNewswire
·
June 26, 2025
SAN FRANCISCO, June 25, 2025 (GLOBE NEWSWIRE) -- A securities class action lawsuit styled Ho v. Rocket Pharmaceuticals, Inc., et al., No. 3:25-cv-10049 (D. N.J.) has been filed and seeks to represent investors who purchased or otherwise acquired Rocket …